References

1. Allampallam K, Chakraborty J, Robinson J. Effect of ascorbic acid and growth factors on collagen metabolism of flexor retinaculum cells from individuals with and without carpal tunnel syndrome. J Occup Environ Med 42(3):251-9, 2000.

2. Awad H A, Butler D L, Boivin G P, Smith F N, Malaviya P, Huibrejtse B. Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng 5(3):267-77, 1997.

3. Butler D L, Awad H A. Perspectives on cell and collagen composites for tendon repair. Clin Orthop (367 suppl):S324-32, 1999.

4. Astrom M, Rausing A. Chronic Achilles tendinopathy. A survey of surgical and histopathological findings. Clin Orthop Jul;(316):151-64, 1995.

5. Cooper B, Oberdorfer ML, Rumpf D, Malakhova O E, Rudman R A, Mariotti A. Trauma modifies strength and composition of retrodiscal tissues of goat temporomandibular joint. Oral Diseases 5:329-336, 1999.

6. Gage J P, Shaw R H, Malone F B. Collagen type in dysfunctional temporomandibular joint disks. J Prosthet Dent 74(5):517-520, 1995.

7. Leadbetter W B, Cell matrix response in tendon injury. Clinics in Sports Medicine Vol II Num 3:533-577, 1992.

8. Liu S H, Yang R S, Al-Shaikh R, Lane J M. Collagen in Tendon, Ligament, and Bone Healing. Clin Orth and Related Res Num 318:265-278, 1995.

9. Maffulli N, Ewen SWB, Waterston SW, et al. Tenocytes from ruptured and tendinopathic Achilles tendons produce greater quantities of Type III collagen than tenocytes from normal Achilles tendons. Am J Sports Med 28(4):499-505, 2000.

10. Mann V, Hobson E E, Li B, Stewart T L, Grant S F, Robins S P, Aspden R M, Ralston S H. A Col1A1 Sp1 binding site polymorphism predisposes to osteoporitic fracture by affecting bone density and quality. J Clin Invest 107(7):899-907, 2001.

11. Mariotti A, Rumpf D, Malakhova O, Cooper B. Gender-specific differences in temporomandibular retrodiscal tissue in the goat. Eur J Oral Sci 108(5): 461-3, 2000.

12. McGuigan F E, Armbrecht G, Smith R, Felsenberg D, Reid D M, Ralston S H. Prediction of osteoporotic fractures by bone densitometry and COL genotyping: a prospective population-based study in men and women. Osteoporosis Int 12(2):91-6, 2001.

13. Riley G P, Harrnil R L, Constant C R, Chard M D, Causton T E, Hazleman B L. Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis 53(6):359-66, 1994.

14. Westling L Temporomandibular joint dysfunction and systemic joint laxity. Swed Dent J Suppl 81:1-79, 1992.

15. Young R G, Butler D L, Weber W, Caplan A I, Gordon S L, Fink D J. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16(4):406-13, 1998.

16. Ireland D, Harrall R, Curry V, Holloway G, Hackney R, Hazleman B, Riley GP. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol June;20(3):159-69, 2001.

17. Riley GP, Cox M, Harrall RL, Clements S, Hazleman BL. Inhibition of tendon cell proliferation and matrix glycosaminoglycan synthesis by non-steroidal anti-inflammatory drugs in vitro. J Hand Surg June;26(3):224-8, 2001.

18. Khan K M, Cook J L, Bonar F, Harcourt P, Astrom M. Histopathology of common tendinopathies. Update and implications for clinical management. Sports Med June;27(6):393-408, 1999.

19. Lee K, Majumdar MK, Buyaner D, Hendricks J K, Pittenger M F, Mosca J D. Human mesenchymal stem cells maintain transgene expression during expansion and differentiation. Mol Ther Jun;3(6):857-66, 2001.

20. Goomer R S, Maris T M, Gelberman R, Boyer M, Silva M, Amiel D. Nonviral in vivo gene therapy for tissue engineering of articular cartilage and tendon repair. Clin Orthop Oct;(379 Suppl):S189-200, 2000.

21. Bonadio J. Tissue engineering via local gene delivery. J Mol Med 78(6):303-11, 2000.

22. Woo S L, Hildebrand K, Watanabe N, Fenwick J A, Papageorgiou C D, Wang J H. Tissue engineering of ligament and tendon healing. Clin Orthop Oct;(367 Suppl):S312-23, 1999.

23. Lou J. In vivo gene transfer into tendon by recombinant adenovirus. Clin Orthop Oct;(379 Suppl):S252-55, 2000.

24. Nakamura N, Hart D A, Boorman R S, Kaneda Y, Shrive N G, Marchuk L L, Shino K, Ochi T, Frank C B. Decorin antisense gene therapy improves functional healing of early rabbit ligament scar with enhanced collagen figrillogenesis in vivo. J Orthop Res Jul;18(4):517-23, 2000.

25. Forslund C, Aspenberg P. Tendon healing stimulated by injected CDMP-2. Med Sci Sports Exerc May;33(5):685-87, 2001.

26. Chang J, Thunder R, Most D, Longaker M T, Lineaweaver W C. Studies in flexor tendon wound healing: neutralizing antibody to TGF-beta1 increases postoperative range of motion. Plast Reconstr Surg Jan;105(1):148-55, 2000.

27. Chang J, Most D, Stelnicki E, Siebert J W, Longaker M T, Hui K, Lineweaver W C. Gene expression of transforming growth factor beta-1 in rabbit zone II flexor tendon wound healing: evidence for dual mechanisms of repair. Plast Reconstr Surg Sep;100(4):937-44, 1997.

28. Murrell G A, Szabo C, Hannafin J A, Jang D, Dolan M M, Deng X H, Murrell D F, Warren R F. Modulation of tendon healing by nitric oxide. Inflamm Res Jan;46(1):19-27, 1997.

29. Lin J H, Wang M X, Wei A, Zhu W, Diwan A D, Murrell G A. Temporal expression of nitric oxide synthase isoforms in healing Achilles tendon. J Orthop Res Jan;19(1):136-42, 2001.

30. Lin J, Wang M X, Wei A, Zhu W, Murrell G A. The cell specific temporal expression of nitric oxide synthase isoforms during achilles tendon healing. Inflamm Res Oct;50(10):515-22, 2001.

31. Murphy D J; Nixon A J. Biochemical and site-specific effects of insulin-like growth factor I on intrinsic tenocyte activity in equine flexor tendons. Am J Vet Res Jan;58(1):103-9, 1997.

32. Conti N A, Dahners L E. The effect of exogenous growth factors on the healing of ligaments. Trans Orthop Res Soc 18:60, 1993.

33. Letson A K, Dahners L E. The effect of combinations of growth factors on ligament healing. Clin Orthop 308;207-212, 1994.

34. Kurtz C A, Loebig T G, Anderson D D, DeMeo P J, Campbell P G. Insulin-like growth factor I accelerates functional recovery from Achilles tendon injury in a rat model. Am J Sports Med May-Jun;27(3):363-69, 1999.

35. Abrahamsson S O. Similar effects of recombinant human insulin-like growth factor I and II on cellular activities in flexor tendons of young rabbits: experimental studies in vitro. J Orthop Res Mar;15(2):256-62, 1997.

36. Aspenberg P, Forslund C. Enhanced tendon healing with GDF 5 and 6. Acta Orthop Scand Feb;70(1):51-54, 1999.

37. Clark R T, Johnson T L, Schalet B J, Davis L, Gaschen V, Hunziker E B, Oldberg A, Mikic B. GDF-5 deficiency in mice leads to disruption of tail tendon form and function. Connect Tissue Res 42(3):175-86, 2001.

38. Lou J, Tu Y, Burns M, Silva M J, Manske P. BMP-12 gene transfer augmentation of lacerated tendon repair. J Orthop Res Nov;19(6):1199-202, 2001.

39. Hart D A, Nakamura N, Marchuk L, Hiraoka H, Boorman R, Kaneda Y, Shrive N G, Frank C B. Complexity of determining cause and effect in vitro after antisense gene therapy. Clin Orthop Oct;(379 Suppl):S242-52, 2000.

40. Riley G P, Harrall R L, Constant C R, Chard M D, Cawston T E, Hazleman B. Glycosaminoglycans of human rotator cuff tendons: changes with age and in chronic rotator cuff tendinitis. Ann Rheum Dis Jun;53(6):367-76, 1994.

41. Khan KM, Cook JL, Taunton JE, et al. Overuse tendinosis, not tendinitis: a new paradigm for a difficult clinical problem. Phys Sportsmed;28(5):38-48, 2000.

42. Khan KM, Cook JL, Maffulli N, Kannus P. Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin. Br J Sports Med;34(2):81-84, 2000.

43. Martinek V, Fu F, Huard J. Gene Therapy and Tissue Engineering in Sports Medicine. Phys Sportsmed; 28(2), 2000.

44. Khan KM, Cook JL, Kannus P, Maffulli N, Bonar SF. Time to abandon the "tendinitis" myth. BMJ;324:626-527, 2002.

45. Maffulli N, Khan KM, Puddu G. Overuse tendon conditions. Time to change a confusing terminology. Arthroscopy;14:840-843, 1998.

46. Gerr F, Marcus M, Ensor C, Kleinbaum D, Cohen S, Edwards A, Gentry E, Ortiz DJ, Monteilh C. A prospective study of computer users: I. Study design and incidence of musculoskeletal symptoms and disorders. Am J Ind Med;Apr:41(4):221-35, 2002.

47. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med;Jun:7(6):259-64, 2001.